These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 27265676

  • 1. Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry Cardiomyopathy.
    Weidemann F, Maier SK, Störk S, Brunner T, Liu D, Hu K, Seydelmann N, Schneider A, Becher J, Canan-Kühl S, Blaschke D, Bijnens B, Ertl G, Wanner C, Nordbeck P.
    Am J Cardiol; 2016 Jul 15; 118(2):264-74. PubMed ID: 27265676
    [Abstract] [Full Text] [Related]

  • 2. Hypertrophic cardiomyopathy: the importance of arrhythmic events in patients at risk for sudden cardiac death.
    Medeiros Pde T, Martinelli Filho M, Arteaga E, Costa R, Siqueira S, Mady C, Piegas LS, Ramires JA.
    Arq Bras Cardiol; 2006 Nov 15; 87(5):649-57. PubMed ID: 17221043
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of implantable loop recorder and Holter electrocardiographic monitoring for the detection of arrhythmias in patients with peripartum cardiomyopathy.
    Hoevelmann J, Sliwa K, Briton O, Ntsekhe M, Chin A, Viljoen C.
    Clin Res Cardiol; 2023 Mar 15; 112(3):379-391. PubMed ID: 36131137
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA, Spirito P.
    N Engl J Med; 2000 Feb 10; 342(6):365-73. PubMed ID: 10666426
    [Abstract] [Full Text] [Related]

  • 5. Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study.
    Dello Russo A, Mangiola F, Della Bella P, Nigro G, Melacini P, Bongiorni MG, Tondo C, Calò L, Messano L, Pace M, Pelargonio G, Casella M, Sanna T, Silvestri G, Modoni A, Zachara E, Moltrasio M, Morandi L, Nigro G, Politano L, Palladino A, Bellocci F.
    J Cardiovasc Med (Hagerstown); 2009 Jan 10; 10(1):51-8. PubMed ID: 19708226
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Management of arrhythmias in patients with Takotsubo cardiomyopathy: Is the implantation of permanent devices necessary?
    Stiermaier T, Rommel KP, Eitel C, Möller C, Graf T, Desch S, Thiele H, Eitel I.
    Heart Rhythm; 2016 Oct 10; 13(10):1979-86. PubMed ID: 27298201
    [Abstract] [Full Text] [Related]

  • 10. High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device.
    Wilke I, Witzel K, Münch J, Pecha S, Blankenberg S, Reichenspurner H, Willems S, Patten M, Aydin A.
    J Cardiovasc Electrophysiol; 2016 Jul 10; 27(7):779-84. PubMed ID: 27060297
    [Abstract] [Full Text] [Related]

  • 11. A primer on arrhythmias in patients with hypertrophic cardiomyopathy.
    Bockstall KE, Link MS.
    Curr Cardiol Rep; 2012 Oct 10; 14(5):552-62. PubMed ID: 22825919
    [Abstract] [Full Text] [Related]

  • 12. Arrhythmias in hypertrophic cardiomyopathy.
    Kuck KH.
    Pacing Clin Electrophysiol; 1997 Oct 10; 20(10 Pt 2):2706-13. PubMed ID: 9358518
    [Abstract] [Full Text] [Related]

  • 13. Incremental Value of an Insertable Cardiac Monitor in Patients with Hypertrophic Cardiomyopathy with Low or Intermediate Risk for Sudden Cardiac Death.
    Sakhi R, Huurman R, Theuns DAMJ, Schinkel AFL, Assaf A, Szili-Torok T, Roos-Hesselink JW, Michels M, Yap SC.
    Cardiology; 2021 Oct 10; 146(2):207-212. PubMed ID: 33477163
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Arrhythmias in Fabry cardiomyopathy.
    Acharya D, Robertson P, Kay GN, Jackson L, Warnock DG, Plumb VJ, Tallaj JA.
    Clin Cardiol; 2012 Dec 10; 35(12):738-40. PubMed ID: 22886820
    [Abstract] [Full Text] [Related]

  • 16. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
    McLELLAN AJ, Ellims AH, Prabhu S, Voskoboinik A, Iles LM, Hare JL, Kaye DM, Macciocca I, Mariani JA, Kalman JM, Taylor AJ, Kistler PM.
    J Cardiovasc Electrophysiol; 2016 May 10; 27(5):571-80. PubMed ID: 26840595
    [Abstract] [Full Text] [Related]

  • 17. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.
    Francia P, Adduci C, Palano F, Semprini L, Serdoz A, Montesanti D, Santini D, Musumeci B, Salvati A, Volpe M, Autore C.
    J Cardiovasc Electrophysiol; 2015 Aug 10; 26(8):893-899. PubMed ID: 25996259
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pilot evaluation of an integrated monitor-adhesive patch for long-term cardiac arrhythmia detection in India.
    Shrivastav M, Padte S, Arora V, Biffi M.
    Expert Rev Cardiovasc Ther; 2014 Jan 10; 12(1):25-35. PubMed ID: 24325206
    [Abstract] [Full Text] [Related]

  • 20. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W, Christ M, Bach J, Müller HH, Maisch B.
    Circulation; 2003 Dec 09; 108(23):2883-91. PubMed ID: 14623812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.